UK Diagnostic Capacity And Spending Below European Average
The UK’s diagnostics sector has faced “significant underinvestment” over recent years, according to researchers at health think tank The King’s Fund. A new report shows how the UK’s spending on diagnostics compares to other European countries.
You may also be interested in...
The European Commission’s proposed Data Act is among a growing pile of horizontal regulations set to impact the medtech industry. But changes should be made to protect trade secrets and other sector-specific nuances, MedTech Europe warns.
UK and EU patients have inadequate and inconsistent access to cancer biomarker tests, which experts warn is hindering the use of life-saving targeted medicines. Could parallel regulatory and reimbursement processes for drugs and diagnostics provide a solution?
UK policymakers will need to walk a fine line when developing regulation for AI as a medical device. An independent expert review sets out the need for carefully balanced rules that support innovation without allowing unsafe products to enter the market.